fbpx

PharmaLedger News Mention: Deloitte

PharmaLedger has been mentioned in an article by Deloitte.

PharmaLedger has been mentioned in an article by Deloitte.

Deloitte, one of the largest multinational advisory companies, has written about blockchain being one of the top strategic priorities for life and sciences executives. In one of its Deloitte Insights titled “The after-effects of the pandemic on life sciences ecosystems,” PharmaLedger was introduced as a new blockchain consortium project in 2020. The article also explores how the pandemic has accelerated the adoption of digitisation, the increase in public education on how new medicine gets to patients and it also discusses blockchain challenges, such as regulatory barriers. The PharmaLedger news mention can be read below:

“Pilot and consortium activity grew, including the launch of PharmaLedger, a global consortium from the Innovative Medicines Initiative (IMI) that brought industry players together to build scalable blockchain solutions to manage governance, compliance, and interoperability.”

PharmaLedger: Opening the Conversation

The COVID pandemic shows that the healthcare system wasn’t fully prepared for such a widespread and urgent matter. We need more mechanisms to share data in a trusted environment and faster supply chains. Imagine if you could check the authenticity of a vaccine through a blockchain-enabled app, or if vaccine distributors could track the real-time shipment throughout the entire supply chain. These are no longer just ideas. In fact, there are initiatives around the world already using blockchain to support the covid pandemic. Trust and transparency are needed more now than ever as the public becomes increasingly interested in these healthcare and medicine processes, which is exactly what we here at PharmaLedger are trying to build with our blockchain-enabled platform and use cases.


We are excited to see the PharmaLedger project mentioned throughout various articles and websites. If you are interested to get the latest news about the PharmaLedger project, sign up for our monthly newsletter below.

Contact

Sign up for our monthly newsletter to stay up to date on all our information, news and activities in just one email a month! Unsubscribe at any time.

Subscribe!

Sign up for our monthly newsletter to stay up to date on all our information, news and activities in just one email a month! Unsubscribe at any time.